Ruby A. Neeson Diabetes Awareness Foundation is committed in proceeding with action on diabetes issues affecting the state of Georgia. Our intention is to help improve the prognosis and quality of health care for all persons affected by diabetes in the state.
According to the Georgia Department of Public Health more than 1 in 10 Georgia adults has diabetes, or more than a million people. Several hundred thousand more Georgians have pre-diabetes, a condition that can be prevented from becoming full diabetes through weight loss, increased physical activity, and better nutrition.
Important Facts about Diabetes in Georgia
- The prevalence of diabetes has increased by almost half since 2000 when an estimated
6.8% of adults had diabetes, compared to 9.7% in 2010.
- Approximately 6.5% of Georgians with diabetes have not been tested and are unaware
they have the disease.
- Georgia’s death rate for diabetes is 8% higher than the national average.1
- Diabetes hospitalizations from Georgia’s Medicaid and State Health Benefit Plan
populations resulted in charges of $30 million in 20132
for just 36,567 admissions.
- As of 2013 the total cost of diabetes in Georgia is approximately $5.1 billion. Of that,
$3.3 billion was attributed to direct medical cost and the remaining $1.8 billion was
attributed to loss of productivity and sick days.
- Georgia currently has only 92 accredited self-management programs, an insufficient
number to meet the needs of the already nearly 1 million people with diabetes.
Our Priority Issues for Action
Congressional Diabetes Caucus: The Congressional Diabetes Caucus has an essential role in helping to constitute legislation, (laws and rules made by the government) to provide Medicare coverage for diabetes self-management education, vital diabetes supplies including blood testing strips, and glucose monitors. The Congressional Diabetes Caucus successfully implored the Centers for Medicare and Medicaid Services to provide coverage for insulin infusion pumps. The Congressional Diabetes Caucuses is in both the US House of Representatives and Senate; and is the largest health caucus in Congress. * Ruby A. Neeson Diabetes Awareness Foundation believes that the entire Georgia Congressional delegation should be a part of the Congressional Diabetes Caucuses. We are taking action with other community members by vigorously reaching out to representatives to ask them to be a part of The Congressional Diabetes Caucus by joining if they are not a member. If your representative is a member we encourage you to periodically thank them. Members can be found here.
* Ruby A. Neeson Diabetes Awareness Foundation believes expanding access to this benefit can help improve people with diabetes quality of life, as well as emerge in better Medicare cost savings.
National Housing Trust Fund: The National Housing Trust Fund (HTF) is focused on the building, rehabilitating, preserving, and operating rental housing for extremely low-income people. According to the National Low Income Housing Coalition, across Georgia, there is a shortage of rental homes affordable and available to extremely low income households, whose incomes are at or below the poverty guideline or 30% of their area median income. Many of these households are severely cost burdened, spending more than half of their income on housing.
* Ruby A. Neeson Diabetes Awareness Foundation believes it is important to undertake the issue of housing disparities by confronting the sky-rocketing distress of unsuitability in housing as unstable housing can amplify an increased risk of diabetes-related emergencies, and poor mental health concerns. Access to supportive housing is important for vulnerable individuals with diabetes. We support efforts that urge congress to protect and expand the HTF.
Most Favored Nation (MFN) Model: Most Favored Nation (MFN) Model, a new Medicare payment model under section 1115A of the Social Security Act (the Act).
* Ruby A. Neeson Diabetes Awareness Foundation believes adequate access to medications, particularly new innovative medicines are vital for diabetes patients who encompass a portion of the population that rely upon frequent medical advancements to manage their condition. We have concerns with reference to an update on the MFN rule; and are unsettled that this federal directive could impact patient access to treatments and future pharmaceutical innovation particularly in the midst of COVID-19 which extends to demonstrate a peril to public health. We have made appeals to members of Georgia Congressional delegation to please oppose the rule.